Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Text messaging increases medication adherence

Study finds patients who received medicine reminders did better at taking their treatment

Text messaging medication adherence

Patients who received text message reminders to take their medicine significantly improved their medication adherence, according to a new study.

Published in Clinical Therapeutics, the report involved 580 people and found 85 per cent of those receiving the alerts followed their oral medicine regimen, while among those that didn't receive the reminders, 77 per cent took their treatment as prescribed.

The findings were particularly striking among patients who were prescribed an oral anti-diabetic drug (91 per cent Vs 82 per cent) or a beta-blocker (88 per cent to 71 per cent).

The study saw a control group of 290 people and another group of the same size that opted-in to receive text message medication-specific dosage-specific reminders for a chronic oral medication, matching the reminders to pharmacy claims for the same medication. 

“Findings suggest that members opting into a text message reminder programme have significantly higher chronic oral medication adherence compared with members not opting to receive medication-specific text message reminders, and that the use of a text message reminder programme assists in preserving higher rates of adherence over time,” the researchers concluded.

Earlier this year an SMS text dose reminder service promoting patient adherence was a key part of a Janssen's MyIncivio hepatitis C patient programme.

Texting was also highlighted in a report last year by mobile operators' assocation GSM World, which praised SMS reminders for medical and vaccination appointments from Mobiltel Bulgaria.

29th May 2012

From: Marketing

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics